About Eutropics Pharmaceuticals
Eutropics Pharmaceuticals is a private company based in Cambridge, Massachusetts. It has reported $350,000 raised in two offerings on Form D since November 2021. Its chief executive is Michael Cardone.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Not yet | Jan 11, 2024 | $0of $350K target | 0 | — | Options, Simple Agreement for Future EquityRule 506(b) | Form D ↗ |
| Nov 3, 2021 | Nov 18, 2021 | $350,000of $2.0M target | 5 | $70,000 | Debt, OptionsRule 506(b) | Form D ↗ |
| Total, two offerings | $350,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Eutropics Pharmaceuticals's Form D filed Jan 11, 2024.
MC
Michael Cardone
CEO and director